These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 30712505)

  • 41.
    Ferrari ML; Malardé V; Grassart A; Salavessa L; Nigro G; Descorps-Declere S; Rohde JR; Schnupf P; Masson V; Arras G; Loew D; Sansonetti PJ; Sauvonnet N
    Proc Natl Acad Sci U S A; 2019 Jul; 116(27):13582-13591. PubMed ID: 31209035
    [TBL] [Abstract][Full Text] [Related]  

  • 42. AroD deletion attenuates Shigella flexneri strain 2457T and makes it a safe and efficacious oral vaccine in monkeys.
    Kärnell A; Cam PD; Verma N; Lindberg AA
    Vaccine; 1993; 11(8):830-6. PubMed ID: 8356844
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Detection of class I integron and its relation to antimicrobial resistance of Shigella flexneri in children].
    Yu H; Wang XH; Ye YZ; Xue JC; Zhu QR
    Zhonghua Er Ke Za Zhi; 2006 Sep; 44(9):680-3. PubMed ID: 17217663
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evaluation of virulent and live Shigella sonnei vaccine candidates in a gnotobiotic piglet model.
    Jeong KI; Venkatesan MM; Barnoy S; Tzipori S
    Vaccine; 2013 Aug; 31(37):4039-46. PubMed ID: 23684833
    [TBL] [Abstract][Full Text] [Related]  

  • 45. How Do the Virulence Factors of
    Mattock E; Blocker AJ
    Front Cell Infect Microbiol; 2017; 7():64. PubMed ID: 28393050
    [No Abstract]   [Full Text] [Related]  

  • 46. The type three secretion system effector protein IpgB1 promotes Shigella flexneri cell-to-cell spread through double-membrane vacuole escape.
    Weddle EA; Köseoğlu VK; DeVasure BA; Agaisse HF
    PLoS Pathog; 2022 Feb; 18(2):e1010380. PubMed ID: 35202448
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Molecular and cellular mechanisms of tissue invasion by Shigella flexneri.
    Zychlinsky A; Perdomo JJ; Sansonetti PJ
    Ann N Y Acad Sci; 1994 Aug; 730():197-208. PubMed ID: 8080171
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Rupture of the intestinal epithelial barrier and mucosal invasion by Shigella flexneri.
    Sansonetti PJ; Tran Van Nhieu G; Egile C
    Clin Infect Dis; 1999 Mar; 28(3):466-75. PubMed ID: 10194063
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Analysis of epithelial cell stress response during infection by Shigella flexneri.
    Mantis N; Prévost MC; Sansonetti P
    Infect Immun; 1996 Jul; 64(7):2474-82. PubMed ID: 8698469
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Saccharomyces boulardii interferes with Shigella pathogenesis by postinvasion signaling events.
    Mumy KL; Chen X; Kelly CP; McCormick BA
    Am J Physiol Gastrointest Liver Physiol; 2008 Mar; 294(3):G599-609. PubMed ID: 18032477
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Neuromodulation of experimental Shigella infection reduces damage to the gut mucosa.
    Svensson L; Bergquist J; Wennerås C
    Microbes Infect; 2004 Mar; 6(3):256-64. PubMed ID: 15026012
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of Saccharomyces boulardii against experimental oral infection with Salmonella typhimurium and Shigella flexneri in conventional and gnotobiotic mice.
    Rodrigues AC; Nardi RM; Bambirra EA; Vieira EC; Nicoli JR
    J Appl Bacteriol; 1996 Sep; 81(3):251-6. PubMed ID: 8810053
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Enteric glia protect against Shigella flexneri invasion in intestinal epithelial cells: a role for S-nitrosoglutathione.
    Flamant M; Aubert P; Rolli-Derkinderen M; Bourreille A; Neunlist MR; Mahé MM; Meurette G; Marteyn B; Savidge T; Galmiche JP; Sansonetti PJ; Neunlist M
    Gut; 2011 Apr; 60(4):473-84. PubMed ID: 21139062
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Shigella flexneri modulates stress granule composition and inhibits stress granule aggregation.
    Vonaesch P; Campbell-Valois FX; Dufour A; Sansonetti PJ; Schnupf P
    Cell Microbiol; 2016 Jul; 18(7):982-97. PubMed ID: 27282465
    [TBL] [Abstract][Full Text] [Related]  

  • 55. ShiA abrogates the innate T-cell response to Shigella flexneri infection.
    Ingersoll MA; Zychlinsky A
    Infect Immun; 2006 Apr; 74(4):2317-27. PubMed ID: 16552062
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mapping of Shigella flexneri's tissue distribution and type III secretion apparatus activity during infection of the large intestine of guinea pigs.
    Nigro G; Arena ET; Sachse M; Moya-Nilges M; Marteyn BS; Sansonetti PJ; Campbell-Valois FX
    Pathog Dis; 2019 Oct; 77(7):. PubMed ID: 31578543
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Improved outcome in shigellosis associated with butyrate induction of an endogenous peptide antibiotic.
    Raqib R; Sarker P; Bergman P; Ara G; Lindh M; Sack DA; Nasirul Islam KM; Gudmundsson GH; Andersson J; Agerberth B
    Proc Natl Acad Sci U S A; 2006 Jun; 103(24):9178-83. PubMed ID: 16740661
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The Shigella flexneri type 3 secretion system is required for tyrosine kinase-dependent protrusion resolution, and vacuole escape during bacterial dissemination.
    Kuehl CJ; Dragoi AM; Agaisse H
    PLoS One; 2014; 9(11):e112738. PubMed ID: 25405985
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Novel inhibitors that target bacterial virulence identified via HTS against intra-macrophage survival of
    Miljkovic M; Lozano S; Castellote I; de Cózar C; Villegas-Moreno AI; Gamallo P; Jimenez-Alfaro Martinez D; Fernández-Álvaro E; Ballell L; Garcia GA
    mSphere; 2023 Oct; 8(5):e0015423. PubMed ID: 37565760
    [No Abstract]   [Full Text] [Related]  

  • 60. Analysis of virulence and inflammatory potential of Shigella flexneri purine biosynthesis mutants.
    Cersini A; Martino MC; Martini I; Rossi G; Bernardini ML
    Infect Immun; 2003 Dec; 71(12):7002-13. PubMed ID: 14638790
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.